Position Statement on Use of GLP-2 Analogues and Other Growth Factors for Adult Patients with Intestinal Failure

The British Intestinal Failure Alliance (BIFA), a Specialist Interest Group of BAPEN have updated their position statement on use of GLP-2 analogues and other growth factors for adult patients with intestinal failure.

BIFA are now asking for feedback on the position statement. The statement can be viewed here: https://bit.ly/BIFAGLP-2.

Please send any comments to: secretary@bapen.org.uk by 24 November 2023.

• The Microbiome of Fruit and Vegetables Positively Influences Diversity in the Gut →
• ← Study Reveals Health Impact of Eating Disorders